<DOC>
	<DOCNO>NCT01361191</DOCNO>
	<brief_summary>The aim study evaluate event free survival three year patient diffuse large B-cell lymphoma poor prognostic factor receive R-MegaCHOP induction therapy . Patients positive PET three cycle R-MegaCHOP receive early salvage treatment R-IFE autologous stem cell transplantation . Patients negative PET three cycle R-MegaCHOP treat three additional cycle R-MegaCHOP without transplant .</brief_summary>
	<brief_title>Early Treatment Stratification Based PET Scan Response Chemotherapy Patients With Diffuse Large B-cell Lymphoma</brief_title>
	<detailed_description>In addition : - To evaluate overall survival three year . - To determine rate global responses complete remission , uncertain partial . - To determine duration complete response treatment termination . - To carry exploratory follow event free survival overall survival 5 year . - To evaluate treatment toxicity accord CTC criterion ( version 3.0 ) National Cancer Institute ( NCI ) . - To asses role PET disease stage response evaluation compare CAT . - To identify predictable response factor 6 cycle treatment R-MegaCHOP administrate every 21 day ; 3 cycle R-MegaCHOP , follow IFE+TAPH patient DLBCL severe prognosis . - To evaluate therapeutic fulfillment R-MegaCHOP R+IFE cycle treatment and/or R-IFE reference delay cycle administration reduction chemotherapy dose ( plan dose administrate planned term ) .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<criteria>1. follicular lymphoma grade III diagnose patient , diffuse large Bcell lymphoma , histologically confirm CD20+ 2. age 18 65 year . Patients age 65 70 year include accord investigator 's criterion regard patient ' global health status absence exclude comorbidity . 3 . IPI adjust age 1 aIPI beta2microglobulin equal high 3 mg/dl 3 . Punctuation ECOG grade 0 4 4 . Life expectancy 12 week 5 . Written inform consent form 6 . New diagnose patient without previous treatment 1 . Existence severe cardiac , pulmonary , neurologic , psychiatric metabolic disease cause lymphoma . 2. uncontrolled high blood pressure ( diastolic pressure rest &gt; 115 mmHg ) 3 . Altered hepatic function ( bilirubin AST/ALT superior equal 2 time superior limit normality ) renal ( creatinine equal superior 1.5 time superior limit normality ) cause lymphoma . 4. malignant neoplasia along past 5 year , except skin tumor , exclude melanoma carcinoma situ cervix 5. patient positive HIV 6. patient transform follicular lymphoma 7. pregnant woman nurse ; woman childbearing age use adequate contraceptive method include study 8. ventricular ejection fraction inferior 50 % 9. patient severe psychiatric disease interfere ability understanding study ( include alcoholism drug addiction )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>DLBCL</keyword>
	<keyword>PET</keyword>
	<keyword>IPI</keyword>
	<keyword>R-MegaCHOP</keyword>
	<keyword>Autologous stem cell transplantation</keyword>
</DOC>